Effects of multiple virus coinfections on disease progression in HIV-Positive patients

被引:13
|
作者
Shieh, B
Chang, MJ
Ko, WC
Chen, EJ
Wu, JC
Lee, CF
Chang, TT
Li, C
机构
[1] Chung Shan Med Univ, Dept Microbiol & Immunol, Taichung 402, Taiwan
[2] Chung Shan Med Univ, Dept Biochem, Taichung 402, Taiwan
[3] Chung Shan Med Univ, Dept Med, Taichung 402, Taiwan
[4] Natl Cheng Kung Univ, Inst Mol Med, Coll Med, Tainan 70101, Taiwan
[5] Natl Cheng Kung Univ, Dept Internal Med, Coll Med, Tainan 70101, Taiwan
[6] Natl Cheng Kung Univ Hosp, Dept Nucl Med, Tainan 70428, Taiwan
[7] Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan
关键词
cytomegalovirus; Epstein-Barr virus; hepatitis B virus; hepatitis C virus; hepatitis G virus; human herpesvirus 8; human immunodeficiency virus; human parvovirus B19; human T-cell lymphotropic virus 1; transfusion-transmitted virus;
D O I
10.1159/000069745
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objective: Since virus infections in AIDS patients are mostly inevitable and as they frequently cause disease deterioration and therapeutic failures, a comprehensive investigation was made of the influence of the coinfections of 9 well-known viruses on disease progression in patients infected with human immunodeficiency virus type 1 (HIV). Methods: A cross-sectional study of 62 HIV-positive patients was conducted to correlate the prevalence rates for the 9 viruses with the alanine aminotransferase (ALT) levels and CD4 cell counts of the patients. Results: The rates of HIV-positive patients infected with the 9 viruses are significantly higher than those of the control groups. Furthermore, almost one third of the patients in the studied group was coinfected with transfusion-transmitted virus (TTV) and manifested significantly higher ALT levels (p = 0.020), and these were raised further if coinfection with TTV and human hepatitis C virus had occurred (p = 0.010). By analyzing CD4 cell counts, the only significant effect on AIDS progression which could be detected was coinfection with human herpesvirus 8. Conclusion: This result confirmed that immune-suppressed persons are more vulnerable to common virus infections. Unlike hepatitis B or C virus, TTV seems to accelerate the progression of chronic hepatitis in HIV-infected patients. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 50 条
  • [21] Vascular access outcomes in HIV-positive patients
    Mistry, Hiren
    Lifford, Rhiannon
    Stephenson, Matthew A.
    Valenti, Domenico
    JOURNAL OF VASCULAR ACCESS, 2012, 13 (04): : 459 - 463
  • [22] Diagnosis and treatment of spondylodiscitis in HIV-positive patients
    Siewe, Jan
    Oppermann, Johannes
    Eysel, Peer
    Zarghooni, Kourosh
    Sobottke, Rolf
    ACTA ORTHOPAEDICA BELGICA, 2013, 79 (05): : 475 - 482
  • [23] Symptomatic anterior uveitis in HIV-positive patients
    Verma, S
    Hughes, JD
    Mabey, D
    Graham, EM
    INTERNATIONAL JOURNAL OF STD & AIDS, 1999, 10 (04) : 268 - 274
  • [24] Management of prostate cancer in HIV-positive patients
    Wosnitzer, Matthew S.
    Lowe, Franklin C.
    NATURE REVIEWS UROLOGY, 2010, 7 (06) : 348 - 357
  • [25] Monitoring of kidney function in HIV-positive patients
    Yombi, J. C.
    Jones, R.
    Pozniak, A.
    Hougardy, J-M
    Post, F. A.
    HIV MEDICINE, 2015, 16 (08) : 457 - 467
  • [26] Response to hepatitis A vaccine in HIV-positive patients
    Weissman, S
    Feucht, C
    Moore, BA
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (02) : 81 - 86
  • [27] Potential benefits of carnitine in HIV-positive patients
    Rezaee, Haleh
    Khalili, Hossein
    Salamzadeh, Jamshid
    Jafari, Sirus
    Abdollahi, Alireza
    FUTURE VIROLOGY, 2012, 7 (01) : 73 - 83
  • [28] Zygomycosis in HIV-positive patients: A review of the literature
    VandenSaffele, JK
    Boelaert, JR
    MYCOSES, 1996, 39 (3-4) : 77 - 84
  • [29] Sublingual allergen immunotherapy in HIV-positive patients
    Iemoli, E.
    Borgonovo, L.
    Fusi, A.
    Magni, C.
    Ricci, E. D.
    Rizzardini, G.
    Piconi, S.
    ALLERGY, 2016, 71 (03) : 412 - 415
  • [30] Total hip replacement in HIV-positive patients
    Graham, S. M.
    Lubega, N.
    Mkandawire, N.
    Harrison, W. J.
    BONE & JOINT JOURNAL, 2014, 96B (04): : 462 - 466